Jodi T Williams
4PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 01, 2024
A uniquely efficacious type of CFTR corrector with complementary mode of action.Valentina Marchesin, Lucile Monnier, Peter Blattmann
|Feb 13, 2024
Discovery of a Novel Orally Active, Selective LPA Receptor Type 1 Antagonist, 4-(4-(2-Isopropylphenyl)-4-((2-methoxy-4-methylphenyl)carbamoyl)piperidin-1-yl)-4-oxobutanoic Acid, with a Distinct Molecular Scaffold.Cyrille Lescop, Christine Brotschi, Jodi T Williams
|Feb 08, 2024
Discovery of Nivasorexant (ACT-539313): The First Selective Orexin-1 Receptor Antagonist (SO1RA) Investigated in Clinical Trials.Jodi T Williams, Martin H Bolli, Christine Brotschi
|Jan 29, 2024
Pyrazole derivatives as selective orexin-2 receptor antagonists (2-SORA): synthesis, structure-activity-relationship, and sleep-promoting properties in rats.Christine Brotschi, Martin H Bolli, John Gatfield
Pageof 1
Frequent Collaborators
3 joint publications
Christine Brotschi
3 joint publications
Martin H Bolli
2 joint publications
John Gatfield
1 joint publications
Catherine Roch
1 joint publications
Thierry Sifferlen
1 joint publications
Alexander Treiber
1 joint publications
Christoph Boss
1 joint publications
Michel A Steiner
1 joint publications
Christoph P Sager
1 joint publications
Valentina Marchesin
